Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jul 27, 2020

Pascal Descargues PhD, Founder and CEO, Genoskin talks about bringing the only living injectable human platform to the market to enable clinical testing of drugs for efficacy and toxicity by biotech and pharmaceutical companies.  Their standardized platform uses real human skin tissue to test the consequences of drugs...


Jul 27, 2020

Pascal Descargues PhD, Founder and CEO, Genoskin talks about bringing the only living injectable human platform to the market to enable clinical testing of drugs for efficacy and toxicity by biotech and pharmaceutical companies. Their standardized platform uses real human skin tissue to test the consequences of drugs...


Dec 11, 2019

Mike Wenger, Vice President of Patient Engagement, TrialScope is thinking about ways to improve the clinical trials process by focusing more on the patients that are being recruited, tracked and retained.  We talk about the need to overcome challenges of enrollment, helping patients find the right clinical trial, and...


Dec 11, 2019

Mike Wenger, Vice President of Patient Engagement, TrialScope is thinking about ways to improve the clinical trials process by focusing more on the patients that are being recruited, tracked and retained.  We talk about the need to overcome challenges of enrollment, helping patients find the right clinical trial, and...


Dec 17, 2018

Jesús Martin-Garcia, CEO, GeNeuro discusses the need for new treatment approaches for multiple sclerosis (MS), a long lasting, often disabling disease of the central nervous system that affects 2.5 million people worldwide.  GeNeuro is developing a potential new approach for treating disease progression, the largest...